The launch of an expanded RNAscope probe portfolio by Bio-Techne is likely to positively impact its stock price in the short term. This expansion enhances the company's product offerings in spatial biology, a growing field, and supports the development of next-generation therapeutics and diagnostics, potentially increasing demand for Bio-Techne's products.